Mood and anxiety disorder patients reported both benefits and worsening from cannabis, rarely consulting doctors

Among 36 patients with mood or anxiety disorders who used cannabis, most continued for symptom coping despite acknowledging cognitive dysfunction and worsening mood with ongoing use, and few consulted medical professionals.

Das, Ankita et al.·Pharmacopsychiatry·2024·n/aQualitative Study
RTHC-05249Qualitativen/a2024RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Qualitative Study
Evidence
n/a
Sample
N=36

What This Study Found

Cannabis use was initiated from curiosity, peer pressure, or treatment dissatisfaction. Continuation was driven by psychotropic effects and symptom coping (mood, insomnia). Over time, users acknowledged negative effects including cognitive dysfunction, worsening mood, and increased anxiety. Concerning patterns included initiation before age 18, mixed medical/recreational use, and rare medical consultation.

Key Numbers

36 patients interviewed. All had mood or anxiety disorder diagnoses. Many initiated use before age 18. Mixed medical and recreational use common. Medical professional consultation was rare.

How They Did This

Qualitative study with 36 adults diagnosed with mood or anxiety disorders (including OCD and PTSD) who currently use cannabis. In-depth interviews explored motivations, perceptions, effects, and patterns of cannabis use. Thematic analysis applied.

Why This Research Matters

The disconnect between perceived and actual effects is clinically important. Patients reported continuing cannabis for symptom relief even as they recognized it was making things worse, highlighting the complexity of self-medication in mental health populations.

The Bigger Picture

With cannabis legalization increasing access, mental health patients are self-treating at growing rates. The finding that patients recognize harm but continue using underscores the need for proactive clinician engagement rather than waiting for patients to raise the topic.

What This Study Doesn't Tell Us

Small qualitative sample from a single setting. Self-selected cannabis-using patients may not represent non-users with the same diagnoses. Canadian context with legal access may differ from other jurisdictions. Qualitative design captures experiences but not prevalence.

Questions This Raises

  • ?What specific cannabis products or dosing patterns are associated with worsening versus improvement?
  • ?Would structured clinician conversations change patients cannabis use patterns?
  • ?Could specific cannabis products (e.g., CBD-dominant) avoid the mood-worsening effects patients reported?

Trust & Context

Key Stat:
Patients recognized harm but continued using for symptom relief
Evidence Grade:
Qualitative study providing rich experiential data. Evidence grading does not apply, but the consistent themes across 36 participants add credibility.
Study Age:
Published in 2024 in Pharmacopsychiatry.
Original Title:
Perceptions, Experiences, and Patterns of Cannabis Use in Individuals with Mood and Anxiety Disorders in the Context of Cannabis Legalization and Medical Cannabis Program in Canada - A Qualitative Study.
Published In:
Pharmacopsychiatry, 57(3), 141-151 (2024)
Database ID:
RTHC-05249

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Uses interviews or focus groups to understand experiences in depth.

What do these levels mean? →

Frequently Asked Questions

Does cannabis help people with anxiety and depression?

Patients in this study initially found cannabis helpful for mood and sleep. However, with continued use, many recognized negative effects including worse mood, increased anxiety, and cognitive problems, yet continued using.

Do mental health patients talk to their doctors about cannabis?

Rarely, according to this study. Despite using cannabis to manage diagnosed conditions, patients seldom consulted medical professionals about their use, potential effects, or possible harms.

Read More on RethinkTHC

Cite This Study

RTHC-05249·https://rethinkthc.com/research/RTHC-05249

APA

Das, Ankita; Hendershot, Christian S; Husain, M Ishrat; Knyahnytska, Yuliya; Elsaid, Sonja; Le Foll, Bernard; Kloiber, Stefan. (2024). Perceptions, Experiences, and Patterns of Cannabis Use in Individuals with Mood and Anxiety Disorders in the Context of Cannabis Legalization and Medical Cannabis Program in Canada - A Qualitative Study.. Pharmacopsychiatry, 57(3), 141-151. https://doi.org/10.1055/a-2264-1047

MLA

Das, Ankita, et al. "Perceptions, Experiences, and Patterns of Cannabis Use in Individuals with Mood and Anxiety Disorders in the Context of Cannabis Legalization and Medical Cannabis Program in Canada - A Qualitative Study.." Pharmacopsychiatry, 2024. https://doi.org/10.1055/a-2264-1047

RethinkTHC

RethinkTHC Research Database. "Perceptions, Experiences, and Patterns of Cannabis Use in In..." RTHC-05249. Retrieved from https://rethinkthc.com/research/das-2024-perceptions-experiences-and-patterns

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.